Colorado Biopharma Co. Settles Stock Split, Share Award Suit
Biopharmaceutical venture Aytu BioPharma Inc. and its shareholders have tentatively settled two Delaware Chancery Court suits accusing the company's CEO and four directors of wrongly awarding themselves more than $10 million...To view the full article, register now.
Already a subscriber? Click here to view full article